Inflammatory bowel diseases

Oral

il-7 Pathway Controls Human T Cell Homing to the Gut and Culminates in Inflammatory Bowel Disease Mucosa

Wednesday, June 14
6:15 PM - 7:45 PM

Signaling networks perpetuating chronic inflammatory bowel diseases remain unclear. Here we report that key players of the IL-7 pathway as well as α4/β7 gut-homing integrins accumulate in diseased colon biopsies. While in mice IL-7 is known to play a role in systemic inflammation, we found that IL-7, specifically in humans, also controls α4/β7 integrin expression and imprints gut-homing specificity on T cells. IL-7 receptor blockade reduced human T cell homing to the gut and colon inflammation in different humanized mouse models of colitis and reduced ex-vivo production of IFNγ by tissues punched from ulcerative colitis patients. In addition, transcriptional analysis of diseased colon mucosa indicated that IL-7 receptor signaling pathway discriminated response to conventional therapies. Our findings suggest that resistance to treatment in inflammatory bowel diseases may occur at least in part by dysregulated IL-7 receptor signaling pathway and point IL-7 as a fuel for gut chronic inflammation.

Lyssia Belarif

PhD student
UMR 1064 ITUN

Presentation(s):

    Send Email for Lyssia Belarif

    Bernard Vanhove

    Dr
    U1064

    Presentation(s):

      Send Email for Bernard Vanhove

      Nicolas Poirier

      Dr
      U1064

      Presentation(s):

        Send Email for Nicolas Poirier


        Assets

        il-7 Pathway Controls Human T Cell Homing to the Gut and Culminates in Inflammatory Bowel Disease Mucosa



        Attendees who have favorited this

        Send Email for il-7 Pathway Controls Human T Cell Homing to the Gut and Culminates in Inflammatory Bowel Disease Mucosa